373 related articles for article (PubMed ID: 37260074)
1. Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy.
Dervenis P; Dervenis N; Smith JM; Steel DH
Cochrane Database Syst Rev; 2023 May; 5(5):CD008214. PubMed ID: 37260074
[TBL] [Abstract][Full Text] [Related]
2. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
Smith JM; Steel DH
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008214. PubMed ID: 26250103
[TBL] [Abstract][Full Text] [Related]
3. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
Martinez-Zapata MJ; Martí-Carvajal AJ; Solà I; Pijoán JI; Buil-Calvo JA; Cordero JA; Evans JR
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008721. PubMed ID: 25418485
[TBL] [Abstract][Full Text] [Related]
4. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
Martinez-Zapata MJ; Salvador I; Martí-Carvajal AJ; Pijoan JI; Cordero JA; Ponomarev D; Kernohan A; Solà I; Virgili G
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD008721. PubMed ID: 36939655
[TBL] [Abstract][Full Text] [Related]
5. Pars plana vitrectomy versus scleral buckling for repairing simple rhegmatogenous retinal detachments.
Znaor L; Medic A; Binder S; Vucinovic A; Marin Lovric J; Puljak L
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009562. PubMed ID: 30848830
[TBL] [Abstract][Full Text] [Related]
6. Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy.
Schwartz SG; Flynn HW; Wang X; Kuriyan AE; Abariga SA; Lee WH
Cochrane Database Syst Rev; 2020 May; 5(5):CD006126. PubMed ID: 32408387
[TBL] [Abstract][Full Text] [Related]
7. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
Smith JM; Steel DH
Cochrane Database Syst Rev; 2011 May; (5):CD008214. PubMed ID: 21563165
[TBL] [Abstract][Full Text] [Related]
8. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
[TBL] [Abstract][Full Text] [Related]
9. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Shalchi Z; Mahroo O; Bunce C; Mitry D
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
[TBL] [Abstract][Full Text] [Related]
10. Laser photocoagulation for proliferative diabetic retinopathy.
Evans JR; Michelessi M; Virgili G
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD011234. PubMed ID: 25420029
[TBL] [Abstract][Full Text] [Related]
11. Face-down positioning or posturing after pars plana vitrectomy for macula-involving rhegmatogenous retinal detachments.
Fung TH; Yim TW; Lois N; Wright DM; Liu SH; Williamson T
Cochrane Database Syst Rev; 2024 Mar; 3(3):CD015514. PubMed ID: 38488250
[TBL] [Abstract][Full Text] [Related]
12. Ocriplasmin for symptomatic vitreomacular adhesion.
Neffendorf JE; Kirthi V; Pringle E; Jackson TL
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD011874. PubMed ID: 29040800
[TBL] [Abstract][Full Text] [Related]
13. Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy.
Schwartz SG; Flynn HW; Lee WH; Wang X
Cochrane Database Syst Rev; 2014 Feb; 2(2):CD006126. PubMed ID: 24532038
[TBL] [Abstract][Full Text] [Related]
14. Monotherapy laser photocoagulation for diabetic macular oedema.
Jorge EC; Jorge EN; Botelho M; Farat JG; Virgili G; El Dib R
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010859. PubMed ID: 30320466
[TBL] [Abstract][Full Text] [Related]
15. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
[TBL] [Abstract][Full Text] [Related]
16. Different lasers and techniques for proliferative diabetic retinopathy.
Moutray T; Evans JR; Lois N; Armstrong DJ; Peto T; Azuara-Blanco A
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012314. PubMed ID: 29543992
[TBL] [Abstract][Full Text] [Related]
17. Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia.
Zhu Y; Zhang T; Xu G; Peng L
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD011160. PubMed ID: 27977064
[TBL] [Abstract][Full Text] [Related]
18. Pars plana vitrectomy with internal limiting membrane flap versus pars plana vitrectomy with conventional internal limiting membrane peeling for large macular hole.
Ghoraba H; Rittiphairoj T; Akhavanrezayat A; Karaca I; Matsumiya W; Pham B; Mishra K; Yasar C; Mobasserian A; Abdelkarem AA; Nguyen QD
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD015031. PubMed ID: 37548231
[TBL] [Abstract][Full Text] [Related]
19. Pars plana lensectomy, pars plana vitrectomy, and silicone oil tamponade as initial management of cataract and combined traction/rhegmatogenous retinal detachment involving the macula associated with severe proliferative diabetic retinopathy.
Douglas MJ; Scott IU; Flynn HW
Ophthalmic Surg Lasers Imaging; 2003; 34(4):270-8. PubMed ID: 12875454
[TBL] [Abstract][Full Text] [Related]
20. Surgical interventions for bilateral congenital cataract in children aged two years and under.
Singh R; Barker L; Chen SI; Shah A; Long V; Dahlmann-Noor A
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD003171. PubMed ID: 36107778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
